Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Academic Article uri icon

Overview

abstract

  • The paraneoplastic neurologic disorders target several families of neuron-specific RNA binding proteins (RNABPs), revealing that there are unique aspects of gene expression regulation in the mammalian brain. Here, we used HITS-CLIP to determine robust binding sites targeted by the neuronal Elav-like (nElavl) RNABPs. Surprisingly, nElav protein binds preferentially to GU-rich sequences in vivo and in vitro, with secondary binding to AU-rich sequences. nElavl null mice were used to validate the consequence of these binding events in the brain, demonstrating that they bind intronic sequences in a position dependent manner to regulate alternative splicing and to 3'UTR sequences to regulate mRNA levels. These controls converge on the glutamate synthesis pathway in neurons; nElavl proteins are required to maintain neurotransmitter glutamate levels, and the lack of nElavl leads to spontaneous epileptic seizure activity. The genome-wide analysis of nElavl targets reveals that one function of neuron-specific RNABPs is to control excitation-inhibition balance in the brain.

publication date

  • September 20, 2012

Research

keywords

  • Brain
  • ELAV Proteins
  • Gene Expression Regulation
  • Glutamic Acid
  • Neurons
  • RNA Splicing

Identity

PubMed Central ID

  • PMC3517991

Scopus Document Identifier

  • 84866505114

Digital Object Identifier (DOI)

  • 10.1016/j.neuron.2012.07.009

PubMed ID

  • 22998874

Additional Document Info

volume

  • 75

issue

  • 6